Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPIAO in severe sepsis with thrombocytopenia
NCT02094248Phase 3Unknown
- Sponsor
- Jinling Hospital
- Start
- Mar 2014
- Primary completion
- Mar 2016
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human thrombopoietin in Thrombocytopenia, sponsored by Jinling Hospital. Status: unknown.
02
Drugs
recombinant human thrombopoietin
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT02094248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02094248.